ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
lexcorp
|
13 |
3.0K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
13
|
3.0K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
lexcorp
|
13 |
3.0K |
7 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
13
|
3.0K
|
7
|
|
Humour
|
|
Re:
Over 45?
|
|
lexcorp
|
9 |
3.0K |
0 |
11/04/24 |
11/04/24 |
Humour
|
9
|
3.0K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Austria-based treatments utilising the OncoSil device
|
|
lexcorp
|
40 |
9.4K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
40
|
9.4K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Austria-based treatments utilising the OncoSil device
|
|
lexcorp
|
40 |
9.4K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
40
|
9.4K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Austria-based treatments utilising the OncoSil device
|
|
lexcorp
|
40 |
9.4K |
3 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
40
|
9.4K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
lexcorp
|
117 |
29K |
1 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
117
|
29K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore secures Singapore and Vietnam market approvals
|
|
lexcorp
|
49 |
19K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
49
|
19K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AVR results presentation at CRT 24 Washington DC 9th to 12th March
|
|
lexcorp
|
65 |
23K |
2 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
65
|
23K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AVR results presentation at CRT 24 Washington DC 9th to 12th March
|
|
lexcorp
|
65 |
23K |
3 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
65
|
23K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Symposium
|
|
lexcorp
|
20 |
7.1K |
0 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
20
|
7.1K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
AVR results presentation at CRT 24 Washington DC 9th to 12th March
|
|
lexcorp
|
65 |
23K |
1 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
65
|
23K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Symposium
|
|
lexcorp
|
20 |
7.1K |
0 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
20
|
7.1K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
lexcorp
|
117 |
29K |
0 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
117
|
29K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
lexcorp
|
117 |
29K |
1 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
117
|
29K
|
1
|
|
ASX - By Stock
|
OPL |
Re:
Opyl matters
|
|
lexcorp
|
9 |
1.4K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
9
|
1.4K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
lexcorp
|
117 |
29K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
117
|
29K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
lexcorp
|
117 |
29K |
3 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
117
|
29K
|
3
|
|
ASX - By Stock
|
LCA |
Re:
FY21
|
|
lexcorp
|
44 |
7.1K |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
44
|
7.1K
|
1
|
|
ASX - By Stock
|
LCA |
Re:
FY21
|
|
lexcorp
|
44 |
7.1K |
1 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
44
|
7.1K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Updated 30-day DurAVR THV Clinical Data
|
|
lexcorp
|
27 |
8.9K |
8 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
27
|
8.9K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Charts
|
|
lexcorp
|
37 |
13K |
8 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
37
|
13K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Charts
|
|
lexcorp
|
37 |
13K |
4 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
37
|
13K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Application for quotation of securities - AVR
|
|
lexcorp
|
21 |
5.0K |
3 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
21
|
5.0K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Updated 30-day DurAVR THV Clinical Data
|
|
lexcorp
|
27 |
8.9K |
3 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
27
|
8.9K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
AVR results presentation at CRT 24 Washington DC 9th to 12th March
|
|
lexcorp
|
65 |
23K |
0 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
65
|
23K
|
0
|
|
Sport
|
|
Re:
NRL racism allegations
|
|
lexcorp
|
120 |
11K |
0 |
12/03/24 |
12/03/24 |
Sport
|
120
|
11K
|
0
|
|
Sport
|
|
Re:
NRL racism allegations
|
|
lexcorp
|
120 |
11K |
0 |
12/03/24 |
12/03/24 |
Sport
|
120
|
11K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
AVR results presentation at CRT 24 Washington DC 9th to 12th March
|
|
lexcorp
|
65 |
23K |
8 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
65
|
23K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
lexcorp
|
114 |
32K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
114
|
32K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
price control
|
|
lexcorp
|
13 |
6.4K |
17 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
13
|
6.4K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
lexcorp
|
114 |
32K |
2 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
114
|
32K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
price control
|
|
lexcorp
|
13 |
6.4K |
2 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
13
|
6.4K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
price control
|
|
lexcorp
|
13 |
6.4K |
3 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
13
|
6.4K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Charts
|
|
lexcorp
|
37 |
13K |
1 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
37
|
13K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Charts
|
|
lexcorp
|
37 |
13K |
9 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
37
|
13K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
lexcorp
|
104 |
43K |
7 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
104
|
43K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
lexcorp
|
104 |
43K |
5 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
104
|
43K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
lexcorp
|
104 |
43K |
2 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
104
|
43K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
lexcorp
|
104 |
43K |
5 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
104
|
43K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Three ViV Patients Completed under Health Canada SAP
|
|
lexcorp
|
28 |
7.7K |
9 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
28
|
7.7K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
lexcorp
|
32 |
11K |
7 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
32
|
11K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Application for quotation of securities - AVR
|
|
lexcorp
|
29 |
9.3K |
6 |
26/01/24 |
26/01/24 |
ASX - By Stock
|
29
|
9.3K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Application for quotation of securities - AVR
|
|
lexcorp
|
29 |
9.3K |
5 |
26/01/24 |
26/01/24 |
ASX - By Stock
|
29
|
9.3K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
lexcorp
|
200 |
55K |
8 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
200
|
55K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Investor Presentation
|
|
lexcorp
|
66 |
20K |
3 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
66
|
20K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Investor Presentation
|
|
lexcorp
|
66 |
20K |
1 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
66
|
20K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
lexcorp
|
200 |
55K |
8 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
200
|
55K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Three ViV Patients Completed under Health Canada SAP
|
|
lexcorp
|
28 |
7.7K |
5 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
28
|
7.7K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
lexcorp
|
200 |
55K |
1 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
200
|
55K
|
1
|
|